Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancer.

Stover DG, Lockhart AC, Berlin JD, Chan E, Sandler AB, Sosman JA, Middlebrook V, Nicol S, Rothenberg ML
Invest New Drugs. 2008 26 (4): 339-45

PMID: 18463792 · DOI:10.1007/s10637-008-9133-4

MeSH Terms (19)

Adult Aged Antineoplastic Combined Chemotherapy Protocols Carcinoma, Squamous Cell Dose-Response Relationship, Drug Fatigue Female Glutamates Guanine Head and Neck Neoplasms Humans Male Maximum Tolerated Dose Middle Aged Neoplasm Metastasis Neutropenia Organoplatinum Compounds Oxaliplatin Pemetrexed

Connections (3)

This publication is referenced by other Labnodes entities: